Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$0.21 - $0.35 $194 - $323
-924 Reduced 6.71%
12,839 $2,000
Q4 2022

Feb 09, 2023

SELL
$0.22 - $0.41 $1 - $2
-5 Reduced 0.04%
13,763 $3,000
Q3 2022

Nov 02, 2022

SELL
$0.41 - $0.64 $1,555 - $2,428
-3,794 Reduced 21.6%
13,768 $5,000
Q2 2022

Aug 01, 2022

SELL
$0.42 - $0.65 $49 - $76
-118 Reduced 0.67%
17,562 $11,000
Q1 2022

May 04, 2022

BUY
$0.54 - $2.74 $647 - $3,285
1,199 Added 7.28%
17,680 $9,000
Q4 2021

Feb 07, 2022

BUY
$2.33 - $3.37 $6,526 - $9,439
2,801 Added 20.48%
16,481 $44,000
Q3 2021

Nov 02, 2021

SELL
$2.52 - $2.99 $1,738 - $2,063
-690 Reduced 4.8%
13,680 $38,000
Q2 2021

Aug 03, 2021

SELL
$2.6 - $3.65 $3,991 - $5,602
-1,535 Reduced 9.65%
14,370 $41,000
Q1 2021

May 04, 2021

SELL
$2.73 - $4.5 $1,351 - $2,227
-495 Reduced 3.02%
15,905 $55,000
Q4 2020

Feb 01, 2021

BUY
$2.6 - $3.32 $4,960 - $6,334
1,908 Added 13.17%
16,400 $43,000
Q3 2020

Nov 09, 2020

SELL
$2.46 - $4.27 $738 - $1,280
-300 Reduced 2.03%
14,492 $45,000
Q2 2020

Aug 07, 2020

BUY
$1.45 - $4.3 $2,544 - $7,546
1,755 Added 13.46%
14,792 $61,000
Q1 2020

May 04, 2020

SELL
$0.75 - $2.55 $2,257 - $7,675
-3,010 Reduced 18.76%
13,037 $21,000
Q4 2019

Feb 04, 2020

BUY
$1.65 - $2.48 $8,685 - $13,054
5,264 Added 48.82%
16,047 $37,000
Q3 2019

Nov 12, 2019

BUY
$1.48 - $2.52 $15,958 - $27,173
10,783 New
10,783 $18,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $373M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.